vimarsana.com

Page 74 - புனே அடிப்படையிலானது சீரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID: India faces vaccine shortage amid surge in new cases | Asia| An in-depth look at news from across the continent | DW

India gives most COVID jabs, but faces vaccine shortages States complain of vaccine scarcity With the ongoing surge, Russia s Sputnik V vaccine was cleared for emergency use by the national drug regulator, the Drugs Controller General of India, on Tuesday. At 91.6%, Sputnik V, which is manufactured in India by Dr. Reddy s labs, has the highest effectiveness, after the Moderna and BioNTech-Pfizer shots. Dr. Reddy s had applied on February 19 for emergency use of the vaccine, which is in Phase 3 of clinical trials in India. It will now be the third vaccine to be cleared for use after Oxford-AstraZeneca vaccine, made by the Pune-based Serum Institute of India (SII), and another, Covaxin, developed by the Hyderabad-based Bharat Biotech.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.